Chembio Diagnostics has acquired 2 companies.
Chembio Diagnostics’ largest acquisition to date was in 2016, when it acquired RVR Diagnostics Sdn Bhd for $2M. Chembio Diagnostics has acquired in 2 countries. The Company’s most targeted sectors include medical products (100%).
555 Wireless Boulevard,
Hauppauge, New York
11788
United States,
(631) 924-1135
www.chembio.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2019-11-07 |
Orangelife Comercio e Industria Ltda. · Medical Products
Rio De Janeiro, Brazil · www.orangelife.com.br Orangelife Comercio e Industria Ltda. is a privately-held Brazilian manufacturer and distributor of point-of-care diagnostics tests for infectious diseases. Orangelife manufactures numerous ANVISA-approved point-of-care infectious disease tests, including Brazil’s first ANVISA-approved HIV self-test. Orangelife tests are manufactured in its Rio de Janeiro, Brazil facility that is ISO-certified and approved by ANVISA to produce Class II/III/IV medical devices. |
- | Add-on Acquisition | - |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
